Matthew E Korenberg
CIK 1649903 · CFO, Treasurer · last filed 2026-06-05
Matthew E Korenberg is a CFO, Treasurer who has filed 58 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for LFCR, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$12.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $13.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$13.37M
4
58
-$12.53M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LFCR | Director | 69,967 | $5.64 | $394.6K | $0 | 3 | 2026-06-05 |
| PVLA | CFO, Treasurer | — | $108.81 | — | $0 | 3 | 2026-02-09 |
| LGND | President & COO | 50,777 | $255.54 | $12.98M | -$12.53M | 50 | 2024-09-24 |
| Qualigen Therapeutics, Inc. (QLGN) Delisted | Director | — | $3.21 | — | $0 | 2 | 2022-08-04 |
Recent Filings
58 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | LFCR | Grant (A) | +25,907 | $0 | EDGAR |
| 2026-02-09 | PVLA | Grant (A) | — | $0 | EDGAR |
| 2025-07-17 | LFCR | Grant (A) | +19,506 | $0 | EDGAR |
| 2025-02-10 | PVLA | Grant (A) | — | $0 | EDGAR |
| 2024-12-17 | PVLA | Grant (A) | — | $0 | EDGAR |
| 2024-09-24 | LGND | Mixed | −1,293 | -$878.1K | EDGAR |
| 2024-09-18 | LGND | Mixed | +2,560 | $226 | EDGAR |
| 2024-08-26 | LGND | Sell (S) | −18,858 | -$1.99M | EDGAR |
| 2024-08-21 | LFCR | Grant (A) | +24,554 | $0 | EDGAR |
| 2024-08-13 | LGND | Sell (S) | −18,245 | -$1.80M | EDGAR |